Quarterly report · Q1
2796.TEDINET S100S04W
Period2023-06-01 → 2023-08-31
Filed2023-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.5bn | 2023-06-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥331m | 2023-06-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥348m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥331m | 2023-06-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥341m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥312m | 2023-06-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥318m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥123m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥333m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥111m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥127m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥114m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥23.6bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥23.4bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥23.2bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.6bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥16.4bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.0bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.9bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥13.11 | 2023-06-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.45 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.88 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.93 | 2023-06-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.89 | 2022-06-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.99 | 2022-06-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.3% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-08-31 | ¥185m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-08-31 | ¥185m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2023-08-31 | −¥78m |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥2.1bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥2.1bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2023-06-01 → 2023-08-31 | −¥9m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥155m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥155m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥11m |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥10.9bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥10.9bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥379m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥27m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥13.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥13.3bn |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥408m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-08-31 | ¥13.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-08-31 | ¥13.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-08-31 | ¥409m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-08-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-08-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-08-31 | ¥21m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-08-31 | −¥75m |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥2.0bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥2.0bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2022-06-01 → 2022-08-31 | −¥35m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥20m |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥398m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥19m |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥12.7bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥12.7bn |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥402m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-08-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-08-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-08-31 | ¥424m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 375
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 尻 慶 太 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)篠 田 友 彦 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 12861000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 13471000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 52030000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 341000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 331000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1431000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 111000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 123000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 333000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 114000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 127000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 372000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 6683000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 6983000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6987000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 23151000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 23553000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 23421000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 11.88 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 13.11 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 35.45 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 8.99 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 9.93 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 26.89 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.276 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.283 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.285 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 9746645 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 9856515 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 9746645 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 9856515 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 321100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 94194 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 9419400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 6145 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 9746645 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 94194 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 321100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 321100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.033 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |